Literature DB >> 7060752

Cocaine self-administration in humans.

M W Fischman, C R Schuster.   

Abstract

Studies are described in which normal healthy volunteers were tested with a wide range of intravenous doses of cocaine of d-amphetamine. Physiological measurements included heart rate, electrocardiogram, blood pressure, respiration rate, and temperature. Behavioral measures included the use of the Profile of Mood States to assess drug-related mood changes, the Addiction Research Center Inventory to assess drug-related changes in verbal reports of their effects, and ratings comparing drug effects of experimentally administered and "street" drugs. In addition, plasma levels of cocaine were monitored to correlate with physiological and behavioral effects. Subjects were also allowed to choose between intravenous injections of cocaine or saline. As with nonhuman research subjects, cocaine was consistently chosen over saline by all subjects tested. The self-administration data and data describing the subjective and cardiovascular spectrum of action were combined to yield a more complete profile of cocaine's action in humans.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7060752

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  33 in total

Review 1.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

2.  Human behavioral pharmacology, past, present, and future: symposium presented at the 50th annual meeting of the Behavioral Pharmacology Society.

Authors:  Sandra D Comer; Warren K Bickel; Richard Yi; Harriet de Wit; Stephen T Higgins; Galen R Wenger; Chris-Ellyn Johanson; Mary Jeanne Kreek
Journal:  Behav Pharmacol       Date:  2010-07       Impact factor: 2.293

3.  Effects of stimulation and blockade of dopamine receptor subtypes on the discriminative stimulus properties of cocaine.

Authors:  R L Barrett; J B Appel
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Effects of the putative dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 on the discriminative stimulus properties of cocaine.

Authors:  P M Callahan; M F Piercey; K A Cunningham
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

5.  EVALUATION OF DRUG ABUSE TREATMENT MEDICATIONS: CONCORDANCE BETWEEN CLINICAL AND PRECLINICAL STUDIES.

Authors:  N K Mello
Journal:  NIDA Res Monogr       Date:  2005-05

Review 6.  The neurocircuitry of addiction: an overview.

Authors:  M W Feltenstein; R E See
Journal:  Br J Pharmacol       Date:  2008-03-03       Impact factor: 8.739

7.  Effects of increasing the magnitude of an alternative reinforcer on drug choice in a discrete-trials choice procedure.

Authors:  M A Nader; W L Woolverton
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

8.  Regulation of cocaine self-administration in humans: lack of evidence for loading and maintenance phases.

Authors:  Gustavo A Angarita; Brian Pittman; Ralitza Gueorguieva; Rasmon Kalayasiri; Wendy J Lynch; Atapol Sughondhabirom; Peter T Morgan; Robert T Malison
Journal:  Pharmacol Biochem Behav       Date:  2009-12-21       Impact factor: 3.533

9.  Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers.

Authors:  Thomas F Newton; Malcolm S Reid; Richard De La Garza; James J Mahoney; Antonio Abad; Rany Condos; Joseph Palamar; Perry N Halkitis; Jurji Mojisak; Ann Anderson; Shou-Hua Li; Ahmed Elkashef
Journal:  Int J Neuropsychopharmacol       Date:  2008-07-29       Impact factor: 5.176

10.  The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers.

Authors:  R De La Garza; J J Mahoney; C Culbertson; S Shoptaw; T F Newton
Journal:  Pharmacol Biochem Behav       Date:  2008-01-22       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.